Medical Journals

Importance of Receptor Usage, Fli1 Activation, and Mouse Strain for the Stem Cell Specificity of 10a1 Murine Leukemia Virus Leukemogenicity.

Authors:
  • Rodenburg Michaela
  • Fischer Meike
  • Engelmann Afra
  • Harbers Stephanie O
  • Ziegler Marion
  • Löhler Jürgen
  • Stocking Carol

From: Heinrich-Pette-Institut, Hamburg, Germany.

Journal of virology

  • Publish Date: Jan 2007
  • ISSN: 0022-538X
  • Volume: 81
  • Issue: 2
  • Pages: 732-42
  • Medium: Print
  • Language: English
  • Citation (JAMA): Rodenburg Michaela, Fischer Meike, Engelmann Afra, et al. Importance of Receptor Usage, Fli1 Activation, and Mouse Strain for the Stem Cell Specificity of 10a1 Murine Leukemia Virus Leukemogenicity.. J. Virol. Jan 2007;81:732-42

Abstract

Murine leukemia viruses (MuLV) induce leukemia through a multistage process, a critical step being the activation of oncogenes through provirus integration. Transcription elements within the long terminal repeats (LTR) are prime determinants of cell lineage specificity; however, the influence of other factors, including the Env protein that modulates cell tropism through receptor recognition, has not been rigorously addressed. The ability of 10A1-MuLV to use both PiT1 and PiT2 receptors has been implicated in its induction of blast cell leukemia. Here we show that restricting receptor usage of 10A1-MuLV to PiT2 results in loss of blast cell transformation capacity. However, the pathogenicity was unaltered when the env gene is exchanged with Moloney MuLV, which uses the Cat1 receptor. Significantly, the leukemic blasts express erythroid markers and consistently contain proviral integrations in the Fli1 locus, a target of Friend MuLV (F-MuLV) during erythroleukemia induction. Furthermore, an NB-tropic variant of 10A1 was unable to induce blast cell leukemia in C57BL/6 mice, which are also resistant to F-MuLV transformation. We propose that 10A1- and F-MuLV actually induce identical (erythro)blastic leukemia by a mechanism involving Fli1 activation and cooperation with inherent genetic mutations in susceptible mouse strains. Furthermore, we demonstrate that deletion of the Icsbp tumor suppressor gene in C57BL/6 mice is sufficient to confer susceptibility to 10A1-MuLV leukemia induction but with altered specificity. In summary, we validate the significance of the env gene in leukemia specificity and underline the importance of a complex interplay of cooperating oncogenes and/or tumor suppressors in determining the pathogenicity of MuLV variants.

Mesh Headings (Keywords): Animals, Cells, Cultured, Fibroblasts, Gene Products, env, Hematopoietic Stem Cells, Leukemia Virus, Murine, Leukemia, Experimental, Mice, Mice, Inbred C57BL, Proto-Oncogene Protein c-fli-1, Receptors, Virus, Retroviridae Infections, Species Specificity, Tumor Virus Infections


Check for Full Text / PubMed Unique Identifier (PMID): 17079317


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.